Michael Robert Martin - 22 Jun 2021 Form 4 Insider Report for Aurinia Pharmaceuticals Inc. (AUPH)

Role
Chief Business Officer
Signature
/s/ Michael Robert Martin
Issuer symbol
AUPH
Transactions as of
22 Jun 2021
Net transactions value
-$68,800
Form type
4
Filing time
23 Jun 2021, 16:06:09 UTC
Previous filing
12 May 2021
Next filing
29 Jul 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AUPH Common Stock Sale $68,800 -5,000 -2.3% $13.76 216,861 22 Jun 2021 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 21, 2021.
F2 Converted to U.S. dollars based on the average daily exchange rate of the Bank of Canada reported on the sold date.